AllDocs -> cancers

research for a cure laboratory without walls National Foundation for Cancer Research Cancer FAQs about liver cancer Frequently Asked Questions about common cancers. Page 2 Cancer FAQs What are the different types of liver cancer ? There are many kinds of tumors than can originate in the liver . Of the four main types that are cancerous (angiosarcomas, cholangiocarcinomas, hepatoblastomas, and hepatocellular carcinomas), hepatocellular carcinoma (also called hepatoma or HCC), is by far the most common, accounting for about 84 percent of all liver cancer cases. HCC starts growing in the hepatocytes, the main type of cell found in the liver . What are the risk factors for liver cancer ? A risk factor is anything that increases a person’s chance of getting a disease. There are several known risk factors ...

Hepatitis B shots reduce liver cancer In July 1984, Taiwan instituted a free, nationwide vaccination campaign against the hepati- tis B virus. The program started with infants, but by the end of the 1980s, preschool and school-age children were also getting the shots. Predictably, hepatitis B cases in Taiwanese children declined by more than 90 percent between 1984 and 1994. Now, a review of Taiwan’s national cancer registry shows that the incidence of liver cancer in Taiwanese children has dropped dramatically as well. Researchers had suspected the same virus often underlies both diseases. To gauge the cancer decline, Taiwanese researchers documented all 294 cases of hepatocel- lular carcinoma, the most common liver cancer , between 1981 and 1994 in children age 6 to 14. The number of cases fell from 26 in 1982 to 8 in 1993, Mei-Hwei Chang’s team at the National Taiwan University in Taipei reports in ...

WhatYouNeedtoKnow— Important information for people who have liver cancer or are at increased risk. Liver Cancer At the American Liver Foundation, we are committed to liver health and we are here to help you. Contact us! © 2006 American Liver Foundation. All rights reserved. The American Liver Foundation is the nation’s leading nonprofit organization promoting liver health and disease prevention. We provide research, education, and advocacy for those affected by liver -related diseases, including hepatitis. This brochure has been reviewed by Robert G. Gish, MD, Chief: Division of Hepatology and Complex GI, California Pacific Medical Center. The information contained in this brochure is provided for information only and does not constitute medical advice. The American Liver Foundation recommends that you consult your physician before pursuing any course ...

1 Radio Frequency Ablation for Primary Liver Cancer Health Technology Literature Review Completed June 2004 Page 2 Radio Frequency Ablation Disclaimer This health technology scientific literature and policy review was prepared by the Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care for the Ontario Health Technology Advisory Committee and developed from analysis, interpretation and comparison of scientific research and/or technology assessments conducted by other organizations. It also incorporates, when available, Ontario data, and information provided by experts and applicants to the Medical Advisory Secretariat to inform the analysis. While every effort has been made to do so, this document may not fully reflect all scientific research available. Additionally, other relevant scientific findings ...

1 Fighting Liver Cancer Blue Faery: The Adrienne Wilson Liver Cancer Association Fighting Liver Cancer Blue Faery: The Adrienne Wilson Liver Cancer Association Sherri Rose Chair, Medical Research Committee Sherri Rose Chair, Medical Research Committee www.bluefaery.org Who is Adrienne Wilson? Who is Adrienne Wilson? Adrienne and I met in a dance class when we were both in high school. We became close friends. We had a dance performance together on April 13, 2001 . One month later , on May 16, 2001, Adrienne was diagnosed with cancer . Adrienne and I met in a dance class when we were both in high school. We became close friends. We had a dance performance together on April 13, 2001 . One month later , on May 16, 2001, Adrienne was diagnosed with cancer ...

P P.O.Box 2345, Beijing 100023,China World J Gastroenterol 2000 ;Apr 6(2):210-215 Email: wcjd@public.bta.net.cn WJG ISSN 1007-9327 CN 14-1219/ R http:// www.wjgnet.com Copyright © 2000 by The WJG Press Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice Jin Hui Yuan 1 , Ru Ping Zhang 1 , Ru Gang Zhang 1 , Li Xia Guo 1 , Xing Wang Wang 1 , Dan Luo 2 , Yong Xie 2 and Hong Xie 1 Subject headings paclitaxel; liver neoplasms; apoptosis; mitoics; in vitro; DNA; RNA; microscopy, wection; mice, nude Yuan JH, Zhang RP, Zhang RG, Guo LX, Wang XW, Luo D, Xie Y, Xie H. Growthinhibiting effects of taxol on human liver cancer in vitro and in nude mice.World J Gastroenterol, 2000;6(2):210-215 ...

Study on environmental etiology of high incidence areas of liver cancer in China Nian Feng Lin 1 , Jie Tang 1 and Hoteyi S. Mohamed Ismael 2 Subject headings liver neoplasms; etiology; epidemiology; water pollution; environmental carcinogens; nitrosamines; china; geology Lin NF, Tang J, Mohamed Ismael HS.Study on environmental etiology of high incidence areas of liver cancer in China. World J Gastroentero , 2000;6(4):572-576 INTRODUCTION China is a country with a high incidence of liver cancer in some areas [1] . Liver cancer has a wide distribution and threatens human health seriously. A ro ugh estimation shows that out of a population of 1.2 × 10 8 in liver cancer areas patients are more than 1.0 × 10 5 . The environment of the liver cancer area is ...

Journal of the Hong Kong Medical Association Vol. 38, No. 4.1986 Editorial Prevention of Primary Liver Cancer E.K. Yeoh Primary liver cancer is among the ten most common cancers to afflict man. It is estimated that globally, there are at least 250,000 new patients with liver cancer each year (1). In Hong Kong, deaths from malignant neoplasms of the liver and intrahepatic ducts ranks second only to lung cancer , among the leading causes of cancer death (2). In 1985, 969 deaths from this malignancy were reported to the Medical & Health Department. There were 740 deaths in males and 229 deaths in females, a crude mortality rate of 26.4 and 8.8 per 100,000 respectively (2). Primary liver cancer includes hepatocellular carcinoma, cholangiocarcinoma, angiosascoma and other extremely rare forms of cancer . Hepatocellular carcinoma however, accounts numerically ...

Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China 1–3 Hani S El-Nezami, Nektaria N Polychronaki, Jing Ma, Huilian Zhu, Wenhua Ling, Eeva K Salminen, Risto O Juvonen, Seppo J Salminen, Tuija Poussa, and Hannu M Mykkänen ABSTRACT Background: In vitro and in vivo studies suggest that selected strains of probiotic bacteria can form tight complexes with aflatoxin B 1 and other carcinogens. Objective: The aim of the present study was to determine whether administration of probiotic bacteria could block the intestinal ab- sorption of aflatoxin B 1 and thereby lead to reduced urinary excre- tion of aflatoxin B 1 -N 7 -guanine (AFB-N 7 -guanine), a marker for a biologically effective dose of aflatoxin exposure. Elevated urinary excretion of ...

EDITORIAL HEPATITIS B VACCINE: A VACCINE FOR THE PREVENTION OF LIVER CANCER . There are 200 million persistent carriers of hepatitis B in the world and an estimated 25% of these carriers will die from cirrhosis of liver and/or hepatocellular carcinoma ’ . The ubiquitous occurrence of hepatitis B has stimulated a W.H.O. global programme of control. The World Health Organisation Consultative Group on Hepatitis which met in Geneva in July, 1983 concluded that “there is now firm evidence of direct cause and effect between hepatitis B virus and one of the com- monest cancers in the world, primary liver cancer ’. The Group also agreed that the availability of safe and effective vaccines against hepatitis B provides a unique opportunity to break the chain of transmission and prevent both acute and chronic liver disease, including liver cancer . The evidence that hepatitis B virus is a cause ...

Issue 1 Jan04 Oncology dept Royal Free NHS trust Department of Surgery and Department of Oncology Surgery for Cancer of the liver At the Royal Free Hospital Page 2 Page 3 Benefits Support groups for those affected by cancer Oncology Counselling service A patients guide to Chemotherapy A patients guide to Radiotherapy Other information available: Cancerbacup booklets: Understanding cancer of the liver Primary liver cancer (fact sheet) Other booklets on all aspects of coping with cancer . The Cancerbacup booklets are available on loan from the radiotherapy and oncology information service -0207 472 6739 or direct from Cancerbacup -0808 8001234 (free of charge). We have many more booklets and leaflets on all aspects of coping with cancer in the Information ...

Liver cancer -results Liver cancer -results John Buscombe John Buscombe Page 2 Methods of treatment Methods of treatment Directed to HCC Directed to HCC Vascular tumours Vascular tumours Supplied by Hep artery Supplied by Hep artery (normal liver also Portal vein) (normal liver also Portal vein) Ability to deliver radioactivity by catheter Ability to deliver radioactivity by catheter 2 main methods 2 main methods Y-90 labelled Y-90 labelled microspheres microspheres Labelled Labelled Lipiodol/Chitosan Lipiodol/Chitosan Page 3 SIR spheres SIR spheres They are tiny glass beads They are tiny glass beads 35 micron in size 35 micron in size Y-90 within ...

!"# !$%&'%(!)* #+%,!-./)01%2!34).3#+%5$6.1/ '%7! 6.3!1 Waikato District Health Board Hepatitis and liver cancer Mortality Introduction Rationale Methodology Data Coverage Period Method Description Interpretation International Classification of Disease Codes (ICD Version 9 & 10) ICD 9 ICD 10 Findings 1 Ethnicity Volume Trend 2 Age Gender Volume Proportion Profile 3 Age Ethnicity Volume Profile - All years 4 Age Ethnicity Volume Proportion Profile (All Years) 5 Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 6 Maori Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 7 Paciifc People Age Standardised Trend - Waikato District Health Board versus NZ rate per 10,000 persons 8 Other Ethnicity Age Standardised Trend - Waikato District Health ...

Background information regarding Austin Health’s new liver cancer treatment What is the treatment for? Certain advanced and inoperable liver cancers. How does it work? The treatment involves using microscopic radiation beads called SIR-Spheres ® that are injected directly into the liver cancers to destroy tumours within the liver that are otherwise inaccessible and inoperable, while minimising harmful side effects to surrounding healthy tissue. For information on the treatment visit www.sirtex.com Can any one with liver cancer have this treatment? Not everyone is suitable for this treatment and must undergo tests in hospital to determine their suitability. How do I find out if I am suitable for this treatment? Visit www.sirtex.com and printout the information to take to your oncologist ( cancer doctor) to discuss your options. ...

Coronary Artery Disease. Coronary artery disease is highlighted by angiogenesis markers p.5 Erectile Dysfunction. Erectile dysfunction is reversed by angiogenic gene therapy in hypercholesterolemia models p.6 Liver Cancer . Cholangiocarcinoma progression is predicted by lymphangiogenesis growth factor p.7 Multiple Sclerosis. Multiple sclerosis relapse correlates with high levels of angiogenesis protein p.8 Wound Healing. Staphylococcus aureus protein hampers angiogenesis and other wound repair mechanisms p.9 Alzheimer Disease. Alzheimer disease key angiogenesis elements are hampered by beta–amyloid p.11 Angiology. Pleiotrophin activation triggers an angiogenic switch in tumors p.12 Angiology. Vascular walls are reservoirs for progenitor cells that propel postnatal ...